# Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization vs Cryotherapy

> **NCT02990221** · PHASE4 · COMPLETED · sponsor: **University of Campania Luigi Vanvitelli** · enrollment: 50 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** Ingenol mebutate
- **PROCEDURE:** cryotherapy

## Key facts

- **NCT ID:** NCT02990221
- **Lead sponsor:** University of Campania Luigi Vanvitelli
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-12
- **Primary completion:** 2018-04-30
- **Final completion:** 2018-07-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02990221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02990221, "Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization vs Cryotherapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02990221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*